S
Stephen Byrne
Researcher at University College Cork
Publications - 179
Citations - 9693
Stephen Byrne is an academic researcher from University College Cork. The author has contributed to research in topics: Pharmacist & Randomized controlled trial. The author has an hindex of 43, co-authored 162 publications receiving 7956 citations. Previous affiliations of Stephen Byrne include Cork University Hospital & Trinity College, Dublin.
Papers
More filters
Journal ArticleDOI
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
TL;DR: STOPP/START version 2 criteria have been expanded and updated for the purpose of minimizing inappropriate prescribing in older people based on an up-to-date literature review and consensus validation among a European panel of experts.
Journal ArticleDOI
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.
TL;DR: StopP/START as discussed by the authors is a screening tool of older persons' prescriptions incorporating criteria for potentially inappropriate drugs called STOPP (Screening Tool of Older Persons' Prescriptions).
Journal ArticleDOI
Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized Patients
TL;DR: STOPP criteria PIMs, unlike Beers criteria Pims, are significantly associated with avoidable ADEs in older people that cause or contribute to urgent hospitalization.
Journal ArticleDOI
Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact
Barbara Hill-Taylor,Ingrid S. Sketris,Jill A. Hayden,Stephen Byrne,D. O'Sullivan,R. Christie +5 more
TL;DR: The evidence of the impact of STOPP/START on clinical, humanistic and economic outcomes in older adults is examined and a systematic review of research studies that describe the application of this criteria was conducted.
Journal ArticleDOI
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.
David J. Stott,Nicolas Rodondi,Patricia M. Kearney,Ian Ford,Rudi G. J. Westendorp,Simon P. Mooijaart,Naveed Sattar,Carole E. Aubert,Drahomir Aujesky,Douglas C. Bauer,Christine Baumgartner,Manuel R. Blum,John Browne,Stephen Byrne,Tinh-Hai Collet,Olaf M. Dekkers,Wendy P. J. den Elzen,Robert S. Du Puy,Graham Ellis,Martin Feller,Carmen Floriani,Kirsty Hendry,Caroline Hurley,J. Wouter Jukema,Sharon Kean,Maria Kelly,Danielle Krebs,Peter Langhorne,Gemma McCarthy,Vera J. C. McCarthy,Alex McConnachie,Mairi McDade,Martina Messow,Anne Marie O'Flynn,David O'Riordan,Rosalinde K. E. Poortvliet,Terence J. Quinn,Audrey Russell,Carol Sinnott,Jan W. A. Smit,H. Anette Van Dorland,Kieran A. Walsh,Elaine Walsh,Torquil Watt,Robbie Wilson,Jacobijn Gussekloo +45 more
TL;DR: Levothyroxine provided no apparent benefits in older persons with subclinical hypothyroidism and there was no significant excess of serious adverse events prespecified as being of special interest.